A clinical phase II study of ProMACE-CytaBOM

J Clin Oncol. 1991 May;9(5):888.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Evaluation
  • Etoposide / administration & dosage
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Methotrexate / administration & dosage
  • Prednisone / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Cytarabine
  • Bleomycin
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
  • Methotrexate

Supplementary concepts

  • PROMACE-CytaBOM protocol